Shaping Drug Development by Starting with the Disease with Roche's Sylke Poehling, Ph.D.

✨ AI Summary

Roche's Sylke Poehling discusses selecting drug modalities based on disease biology.
An integrated Center of Excellence reduces risk and accelerates progress.
Genomic medicines are a key focus for future development.

Guests on This Episode

SP

Sylke Poehling, Ph.D

2 podcast appearances

Oct 12, 2026 · 0:49:23

Oct 8, 2026 · 0:24:46

Oct 7, 2026 · 0:40:00

Oct 5, 2026 · 0:59:52